Tadalafil SR 7mg (Right Value) – Misbranding (2018)
Class III: A situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences
Class III recall indicates unlikely adverse health consequences.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Tadalafil SR 7 mg Capsules packed in 8,13, 20, 30, 40 or 60 dram screw top pill bottle, Carie Boyd's Prescription Shop 122 Grapevine Hwy. Hurst, TX 76054. NDC 99999-9970-88
Brand
Right Value Drug Stores, Inc.
Lot Codes / Batch Numbers
Lots: 04242018@16 Exp. 10/21/2018, 05042018@17 Exp. 10/31/2018, 07232018@13 Exp. 01/19/2019, 08032018@2 Exp. 01/30/2019
Products Sold
Lots: 04242018@16 Exp. 10/21/2018; 05042018@17 Exp. 10/31/2018; 07232018@13 Exp. 01/19/2019; 08032018@2 Exp. 01/30/2019
Right Value Drug Stores, Inc. is recalling Tadalafil SR 7 mg Capsules packed in 8,13, 20, 30, 40 or 60 dram screw top pill bottle, Carie Boyd's due to Labeling Not Elsewhere Classified: Misbranding.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Labeling Not Elsewhere Classified: Misbranding.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
CA, IN
Page updated: Jan 7, 2026